Scientific and Regulatory Lessons Learnt on Building a Chemistry, Manufacturing, and Controls (CMC) Package for COVID-19 Variant Vaccine Updates in the EU—A Regulator’s Perspective

During the COVID-19 pandemic, eight COVID-19 vaccines were authorised in the European Union (EU); as a result of emerging SARS-CoV-2 variants and waning immunity, some of these have been adapted to broaden the immunity against circulating variants. The pace at which variants emerge challenges the te...

Full description

Saved in:
Bibliographic Details
Main Authors: Ragini Shivji, Elena Grabski, Veronika Jekerle
Format: Article
Language:English
Published: MDPI AG 2024-10-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/12/11/1234
Tags: Add Tag
No Tags, Be the first to tag this record!